Status:
COMPLETED
The Role of Genetics in Weight Loss
Lead Sponsor:
University of Helsinki
Conditions:
Body Mass Index (BMI)
Eligibility:
All Genders
35-65 years
Phase:
NA
Brief Summary
The prevalence of both overweight and obesity is increasing at an alarming rate worldwide. In fact, it is estimated that 2.16 billion adults (38%) will be overweight and 1.12 billion adults (20%) will...
Eligibility Criteria
Inclusion
- 30-65 years old
- body mass index (BMI) of 25-35
- participants with genetic data available
- participants with a valid recontacting informed consent to their biobank
Exclusion
- diagnosis of type I and II Diabetes Mellitus
- history of bariatric surgery
- diagnosis of schizophrenia and intellectual disability
- diagnosis of dementia and Parkinson's
- diagnosis of visual impairment
- diagnosis of multiple sclerosis
- pregnancy or breastfeeding during enrollment screening
Key Trial Info
Start Date :
October 2 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 16 2024
Estimated Enrollment :
238 Patients enrolled
Trial Details
Trial ID
NCT06092372
Start Date
October 2 2023
End Date
December 16 2024
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Finnish Clinical Biobank Tampere
Tampere, Pirkanmaa, Finland, 33520